<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="http://www.fernandotazon.com.es/wp-content/plugins/google-sitemap-generator/sitemap.xsl"?><!-- generator="wordpress/3.5.1" -->
<!-- sitemap-generator-url="http://www.arnebrachhold.de" sitemap-generator-version="3.2.9" -->
<!-- generated-on="21 May, 2013 19:35" -->
<!-- Debug: Total comment count: 991 -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">	<url>
		<loc>http://www.fernandotazon.com.es/</loc>
		<lastmod>2013-05-13T07:47:13+00:00</lastmod>
		<changefreq>daily</changefreq>
		<priority>1.0</priority>
	</url>
<!-- Debug: Start Postings -->
<!-- Debug: Priority report of postID 3346: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/05/13/ven-a-redactar-tu-propio-manual-de-calidad-farmaceutico/</loc>
		<lastmod>2013-05-13T07:47:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3341: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/05/03/requisitos-para-la-importacion-de-apis-en-la-eu-parte-22/</loc>
		<lastmod>2013-05-03T07:25:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3333: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/05/03/requisitos-para-la-importacion-de-apis-en-la-eu-parte-12/</loc>
		<lastmod>2013-05-03T07:24:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.fernandotazon.com.es/clientes/</loc>
		<lastmod>2013-04-11T17:18:27+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 3315: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/04/10/cuantos-lotes-de-validacion-son-necesarios/</loc>
		<lastmod>2013-04-10T16:02:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 120: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/25/ich-q9-quality-risk-management/</loc>
		<lastmod>2013-03-23T10:08:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 172: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/18/feliz-navidad/</loc>
		<lastmod>2013-03-23T10:03:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 179: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/31/fda-modifica-la-cgmp-guide-parte-3/</loc>
		<lastmod>2013-03-23T09:58:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 178: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/31/fda-modifica-la-cgmp-guide-parte-2/</loc>
		<lastmod>2013-03-23T09:58:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 176: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/31/fda-modifica-la-cgmp-guide-parte-1/</loc>
		<lastmod>2013-03-23T09:57:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 197: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/28/buenas-practicas-de-transporte-de-medicamentos-2%c2%aa-parte/</loc>
		<lastmod>2013-03-23T09:52:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 219: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/20/fda-lista-de-guias-nuevas-revisadas-y-retiradas/</loc>
		<lastmod>2013-03-23T09:50:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 407: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/10/fda-actualiza-las-cgmp/</loc>
		<lastmod>2013-03-23T09:48:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1701: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/09/05/fda-actualiza-la-forma-de-realizar-una-pai/</loc>
		<lastmod>2013-03-23T09:46:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 705: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/23/feliz-navidad-2/</loc>
		<lastmod>2013-03-23T09:44:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1469: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/04/23/validacion-de-procesos-nuevos-requisitos-europeos/</loc>
		<lastmod>2013-03-23T09:40:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1582: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/07/02/normas-gmp-para-industria-cosmetica/</loc>
		<lastmod>2013-03-23T09:35:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1622: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/08/23/reduccion-de-los-costes-de-cualificacion-y-validacion/</loc>
		<lastmod>2013-03-23T09:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1742: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/10/27/analisis-de-riesgos-en-control-de-calidad/</loc>
		<lastmod>2013-03-23T09:27:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1788: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/12/13/condiciones-durante-el-transporte/</loc>
		<lastmod>2013-03-23T09:17:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1836: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/01/04/control-de-calidad-cambios-en-el-capitulo-6-de-las-gmp/</loc>
		<lastmod>2013-03-23T09:13:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1887: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/16/exito-en-la-trilogia-de-produccion/</loc>
		<lastmod>2013-03-23T09:11:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1912: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/17/importantes-novedades-en-el-site-master-file/</loc>
		<lastmod>2013-03-23T09:08:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2035: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/04/las-gmp-para-apis-de-la-pics/</loc>
		<lastmod>2013-03-23T09:03:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2074: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/07/01/desarrollo-y-fabricacion-de-principios-activos-farmaceuticos/</loc>
		<lastmod>2013-03-23T08:59:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2122: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/08/23/programa-de-inspeccion-internacional-de-apis/</loc>
		<lastmod>2013-03-23T08:57:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2186: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/09/02/trilogia-del-agua-purificada/</loc>
		<lastmod>2013-03-23T08:52:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2229: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/10/27/gran-exito-en-el-curso-de-diseno-de-experimentos-doe/</loc>
		<lastmod>2013-03-23T08:50:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2324: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/07/trilogia-de-instrumentacion-analitica/</loc>
		<lastmod>2013-03-23T08:43:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3239: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/03/19/importacion-de-apis-en-la-union-europea/</loc>
		<lastmod>2013-03-19T16:39:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.fernandotazon.com.es/nuestro-estilo/</loc>
		<lastmod>2013-03-18T08:43:36+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.fernandotazon.com.es/soluciones/</loc>
		<lastmod>2013-03-18T08:42:05+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 3222: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/03/15/gdp-buenas-practicas-de-distribucion-de-la-eu/</loc>
		<lastmod>2013-03-15T08:28:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2217: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/10/06/steve/</loc>
		<lastmod>2013-03-14T06:39:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2364: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/16/certificado-de-importacion-para-apis-de-paises-fuera-de-la-ue/</loc>
		<lastmod>2013-03-14T06:24:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2401: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/22/gestion-de-incidencias-desviaciones-y-no-conformidades/</loc>
		<lastmod>2013-03-14T06:22:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2682: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/05/07/seguridad-y-eficacia-de-medicamentos/</loc>
		<lastmod>2013-03-14T06:18:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2697: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/05/08/prepararse-para-una-inspeccion-de-gestion-de-riesgos/</loc>
		<lastmod>2013-03-14T06:17:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2893: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/04/ensayos-de-liberacion-a-tiempo-real-rtrt-22/</loc>
		<lastmod>2013-03-14T06:14:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2388: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/22/the-capa-world-gestion-efectiva-de-incidencias-y-desviaciones/</loc>
		<lastmod>2013-03-08T11:37:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2823: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/09/15/la-validacion-de-procesos-de-la-ema-45/</loc>
		<lastmod>2013-03-08T11:34:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2966: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/24/auditorias-a-proveedores/</loc>
		<lastmod>2013-03-08T11:33:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2981: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/25/presentacion-sobre-la-validacion-de-procesos/</loc>
		<lastmod>2013-03-08T11:32:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3011: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/02/taller-100-practico-nuevo-capitulo-1-de-las-gmp-eu/</loc>
		<lastmod>2013-03-08T11:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3186: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/03/05/glp-buenas-practicas-de-laboratorio-bpl/</loc>
		<lastmod>2013-03-08T06:07:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>http://www.fernandotazon.com.es/quienes-somos/</loc>
		<lastmod>2013-03-07T21:45:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
	<url>
		<loc>http://www.fernandotazon.com.es/contacto/</loc>
		<lastmod>2013-03-07T21:45:42+00:00</lastmod>
		<changefreq>weekly</changefreq>
		<priority>0.6</priority>
	</url>
<!-- Debug: Priority report of postID 869: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/17/reacciones-a-nueva-guia-fda-sobre-validacion-de-procesos-12/</loc>
		<lastmod>2013-03-07T21:37:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2996: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/25/presentacion-sobre-liberacio-a-tiempo-real/</loc>
		<lastmod>2013-03-07T21:30:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3054: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/02/taller-100-practico-nuevos-productos-en-plantas-multiproducto/</loc>
		<lastmod>2013-03-07T19:56:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3076: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/04/taller-100-practico-doe-diseno-de-experimentos/</loc>
		<lastmod>2013-03-07T19:55:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2911: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/05/actualizacion-de-los-anexos-15-y-17-de-las-gmp-eu/</loc>
		<lastmod>2013-03-07T19:49:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3164: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/02/11/contaminacion-cruzada-en-las-gmp-eu/</loc>
		<lastmod>2013-02-11T15:48:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3139: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/02/03/media-fill-test-validacion-de-procesos-asepticos/</loc>
		<lastmod>2013-02-03T11:09:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3127: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/02/03/verificacion-continua-de-procesos-y-liberacion-a-tiempo-real/</loc>
		<lastmod>2013-02-03T10:40:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3113: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/27/desinfectantes-en-areas-de-ambiente-controlado/</loc>
		<lastmod>2013-01-27T10:49:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3101: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/24/curso-microbiologia-y-monitorizacion-ambiental/</loc>
		<lastmod>2013-01-24T11:18:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3094: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/24/formacion-en-process-understanding/</loc>
		<lastmod>2013-01-24T10:34:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3039: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2013/01/02/taller-100-practico-control-de-riesgos-de-contaminacion-cruzada/</loc>
		<lastmod>2013-01-02T10:18:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2948: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/18/formacion-practica-en-sistema-capa-efectivo/</loc>
		<lastmod>2012-12-18T11:17:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2921: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/17/formacion-practica-en-gestion-de-riesgos/</loc>
		<lastmod>2012-12-17T10:43:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2881: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/12/04/ensayos-de-liberacion-a-tiempo-real-rtrt-12/</loc>
		<lastmod>2012-12-04T07:58:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2855: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/09/17/la-validacion-de-procesos-de-la-ema-55/</loc>
		<lastmod>2012-09-17T05:46:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2810: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/09/11/la-validacion-de-procesos-de-la-ema-35/</loc>
		<lastmod>2012-09-11T17:23:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2779: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/09/07/la-validacion-de-procesos-de-la-ema-25/</loc>
		<lastmod>2012-09-07T07:50:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2757: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/09/03/la-validacion-de-procesos-de-la-ema-15/</loc>
		<lastmod>2012-09-03T14:23:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2718: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/05/09/apis-que-no-cumplen-gmp/</loc>
		<lastmod>2012-05-09T16:40:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2657: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/26/la-validacion-de-procesos-en-la-eu/</loc>
		<lastmod>2012-04-26T16:00:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2643: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/15/cadena-de-suministros-farmaceutica-pharmaceutical-supply-chain/</loc>
		<lastmod>2012-04-15T15:45:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2627: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/15/seguridad-de-medicamentos-safety-medicines/</loc>
		<lastmod>2012-04-15T07:44:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2585: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/08/elementos-del-desarrollo-farmaceutico-moderno-ii/</loc>
		<lastmod>2012-04-08T09:08:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2561: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/08/elementos-del-desarrollo-farmaceutico-moderno-i/</loc>
		<lastmod>2012-04-08T09:06:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2549: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/04/07/calculo-de-limites-en-la-validacion-de-limpiezas/</loc>
		<lastmod>2012-04-07T13:49:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2486: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/03/11/pharmaceutical-essentials-2012/</loc>
		<lastmod>2012-03-11T12:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2464: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/03/01/practica-en-analisis-de-riesgos/</loc>
		<lastmod>2012-03-01T07:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2450: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/02/18/transferencia-de-tecnologia-en-industria-farmaceutica/</loc>
		<lastmod>2012-02-18T10:22:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2443: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/02/17/seminario-de-formacion-pharmaceutical-quality-management-system/</loc>
		<lastmod>2012-02-17T08:47:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2428: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2012/01/16/excipientes-farmaceuticos-good-distribution-practice-gdp/</loc>
		<lastmod>2012-01-16T09:33:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2348: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/08/intensive-training-course-research-development/</loc>
		<lastmod>2011-12-08T10:58:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2339: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/08/riesgos-en-instalaciones-dedicadas-o-compartidas/</loc>
		<lastmod>2011-12-08T10:21:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2316: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/07/el-edqm-sigue-retirando-ceps/</loc>
		<lastmod>2011-12-07T12:56:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2293: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/12/07/no-es-suficiente-mantener-solo-cromatogramas-impresos/</loc>
		<lastmod>2011-12-07T12:03:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2264: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/11/18/la-trilogia-del-agua-purificada-a-estado-excelente/</loc>
		<lastmod>2011-11-18T15:26:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2244: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/10/30/analisis-de-riesgos-y-espacio-de-diseno/</loc>
		<lastmod>2011-10-30T15:11:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2177: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/09/01/agua-para-inyectables-por-filtracion-por-membrana/</loc>
		<lastmod>2011-09-01T15:57:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2163: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/08/26/validacion-de-metodos-bioanaliticos/</loc>
		<lastmod>2011-08-26T15:56:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2145: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/08/24/transferencia-de-procesos-y-transferencia-de-metodos-analiticos-parte-2/</loc>
		<lastmod>2011-08-24T10:36:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2131: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/08/24/transferencia-de-procesos-y-transferencia-de-metodos-analiticos-parte-1/</loc>
		<lastmod>2011-08-24T09:47:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2110: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/08/04/documentacion-gmp-para-apis-esteriles/</loc>
		<lastmod>2011-08-04T16:03:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2088: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/07/06/curso-practico-de-diseno-de-experimentos/</loc>
		<lastmod>2011-07-06T06:58:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2064: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/20/evaluacion-del-riesgo-medioambiental-de-medicamentos-de-uso-humano-2%c2%aa-parte/</loc>
		<lastmod>2011-06-20T12:11:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2055: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/20/evaluacion-del-riesgo-medioambiental-de-medicamentos-de-uso-humano-1%c2%aa-parte/</loc>
		<lastmod>2011-06-20T11:02:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2046: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/12/informacion-sobre-fabricantes-de-apis-y-contract-manufactures/</loc>
		<lastmod>2011-06-12T09:48:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2024: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/04/prioridades-estrategicas-de-fda-para-2011-2015/</loc>
		<lastmod>2011-06-04T10:40:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 2012: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/06/04/nuevos-requisitos-europeos-para-importar-apis-y-excipientes-farmaceuticos/</loc>
		<lastmod>2011-06-04T09:19:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1998: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/05/23/la-fda-pregunta-como-mejorar-la-legislacion-actual/</loc>
		<lastmod>2011-05-23T11:35:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1991: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/05/20/garantia-de-calidad-como-herramienta-de-productividad/</loc>
		<lastmod>2011-05-20T11:03:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1981: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/05/10/capa-es-la-desviacion-mas-frecuente-en-inspecciones-fda/</loc>
		<lastmod>2011-05-10T06:21:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1967: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/03/19/trilogia-de-garantia-de-calidad/</loc>
		<lastmod>2011-03-19T13:27:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1947: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/03/19/la-trilogia-de-control-de-calidad-ha-sido-otro-exito/</loc>
		<lastmod>2011-03-19T12:20:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1938: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/03/01/que-esperan-los-inspectores-en-las-auditorias-a-fabricantes-de-apis/</loc>
		<lastmod>2011-03-01T15:17:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1930: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/25/la-ema-publica-q9-y-q10-en-la-parte-iii-de-las-gmp/</loc>
		<lastmod>2011-02-25T07:32:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1920: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/22/aplicacion-de-ich-q8-q9-y-q10-por-fda/</loc>
		<lastmod>2011-02-22T17:15:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1904: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/17/trilogia-de-control-de-calidad/</loc>
		<lastmod>2011-02-17T09:35:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1875: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/02/07/novedades-en-la-validacion-de-procesos/</loc>
		<lastmod>2011-02-07T17:40:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1858: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/01/06/monitorizacion-microbiologica-de-salas-limpias/</loc>
		<lastmod>2011-01-06T15:17:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1848: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/01/06/aclaraciones-sobre-el-analisis-de-riesgos/</loc>
		<lastmod>2011-01-06T11:41:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1805: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2011/01/04/curso-practico-de-analisis-de-riesgos-en-mayo/</loc>
		<lastmod>2011-01-04T10:36:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1796: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/12/13/como-saber-si-un-cep-esta-suspendido/</loc>
		<lastmod>2010-12-13T19:12:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1774: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/12/13/elementos-del-sistema-de-calidad-farmaceutico/</loc>
		<lastmod>2010-12-13T14:21:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1765: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/10/27/trilogias-farmaceuticas/</loc>
		<lastmod>2010-10-27T15:22:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1728: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/10/22/jornada-de-normas-de-correcta-fabricacion-de-medicamentos/</loc>
		<lastmod>2010-10-22T12:56:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1717: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/09/21/conferencia-sobre-analisis-de-riesgos/</loc>
		<lastmod>2010-09-21T17:21:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1692: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/09/01/apis-de-india-y-de-china/</loc>
		<lastmod>2010-09-01T17:22:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1681: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/08/31/iso-15378-material-de-acondicionamiento-primario/</loc>
		<lastmod>2010-08-31T06:46:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1674: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/08/30/retirada-de-mercado-de-productos-farmaceuticos-en-usa/</loc>
		<lastmod>2010-08-30T15:02:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1651: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/08/29/formacion-risk-based-quality-control/</loc>
		<lastmod>2010-08-29T12:43:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1630: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/08/29/primer-seminario-sobre-risk-based-manufacturing/</loc>
		<lastmod>2010-08-29T11:31:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1614: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/07/23/analisis-de-riesgos-para-principios-activos/</loc>
		<lastmod>2010-07-23T08:51:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1591: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/07/13/acreditacion-gmp-para-medicamentos-de-terapia-celular/</loc>
		<lastmod>2010-07-13T07:35:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1575: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/06/29/ich-q10-sistema-de-calidad-farmaceutico-parte-2/</loc>
		<lastmod>2010-06-29T20:51:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1567: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/06/29/ich-q10-sistema-de-calidad-farmaceutico-parte-1/</loc>
		<lastmod>2010-06-29T20:23:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1555: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/06/29/ich-q8-q9-y-q10-respuestas-a-algunas-preguntas-parte-4/</loc>
		<lastmod>2010-06-29T19:56:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1543: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/06/11/ich-q8-q9-y-q10-respuestas-a-algunas-preguntas-parte-3/</loc>
		<lastmod>2010-06-11T14:08:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1521: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/05/13/ich-q8-q9-y-q10-respuestas-a-algunas-preguntas-parte-2/</loc>
		<lastmod>2010-05-13T06:49:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1509: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/05/13/ich-q8-q9-y-q10-algunas-respuestas-a-algunas-preguntas-parte-1/</loc>
		<lastmod>2010-05-13T06:21:58+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1498: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/05/12/2a-jornada-sobre-garantia-de-calidad-de-productos-cosmeticos/</loc>
		<lastmod>2010-05-12T06:50:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1491: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/05/11/encuesta-sobre-agua-para-inyectables/</loc>
		<lastmod>2010-05-11T20:07:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1481: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/05/11/trazabilidad-de-medicamentos-y-fda/</loc>
		<lastmod>2010-05-11T17:53:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1462: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/04/23/las-futuras-gmp-para-excipientes/</loc>
		<lastmod>2010-04-23T11:33:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1451: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/04/09/biotecnologia-y-validacion-de-procesos-biotecnologicos/</loc>
		<lastmod>2010-04-09T06:58:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1430: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/04/08/risk-based-manufacturing/</loc>
		<lastmod>2010-04-08T10:20:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1411: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/04/01/nuevo-reglamento-europeo-de-cosmeticos-en-fase-de-implantacion/</loc>
		<lastmod>2010-04-01T08:53:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1397: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/03/23/la-parte-3-de-las-gmp/</loc>
		<lastmod>2010-03-23T17:34:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1364: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/03/09/seminario-de-formacion-sobre-reduccion-de-costes/</loc>
		<lastmod>2010-03-09T11:24:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1351: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/02/08/nuevo-laboratorio-aprobado-gracias-a-asinfarma/</loc>
		<lastmod>2010-02-08T18:13:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1341: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/02/08/bienvenidos-a-nuestra-pagina-web/</loc>
		<lastmod>2010-02-08T14:55:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1319: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/01/08/programa-de-seminarios-2010/</loc>
		<lastmod>2010-01-08T09:57:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1302: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2010/01/02/garantia-de-calidad-como-factor-de-productividad/</loc>
		<lastmod>2010-01-02T10:24:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1284: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/12/31/cambios-importantes-en-emea/</loc>
		<lastmod>2009-12-31T19:24:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1277: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/11/19/radiofarmacos-basados-en-anticuerpos-monoclonales/</loc>
		<lastmod>2009-11-19T15:32:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1268: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/11/12/nuevo-procedimiento-de-fda-para-una-warning-letter/</loc>
		<lastmod>2009-11-12T13:44:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1247: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/10/08/curso-de-normas-gmp-para-industria-cosmetica/</loc>
		<lastmod>2009-10-08T12:07:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1238: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/30/subcontratar-auditorias-a-fabricantes-de-apis/</loc>
		<lastmod>2009-09-30T06:10:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1227: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/22/analisis-de-riesgos-otro-seminario-con-exito/</loc>
		<lastmod>2009-09-22T14:00:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1220: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/11/consideraciones-importantes-sobre-el-espacio-de-diseno/</loc>
		<lastmod>2009-09-11T16:26:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1213: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/07/gmp-para-principios-activos/</loc>
		<lastmod>2009-09-07T14:29:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1201: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/07/validacion-de-procesos-asepticos/</loc>
		<lastmod>2009-09-07T09:44:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1187: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/07/programa-de-formacion-en-terapias-avanzadas/</loc>
		<lastmod>2009-09-07T09:44:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1194: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/07/excipientes-y-desarrollo-farmaceutico/</loc>
		<lastmod>2009-09-07T07:32:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1180: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/04/reglamento-europeo-sobre-terapias-avanzadas/</loc>
		<lastmod>2009-09-04T10:27:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1172: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/09/04/medicamentos-de-terapia-avanzada/</loc>
		<lastmod>2009-09-04T09:20:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1136: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/08/23/seminario-practico-de-analisis-de-riesgos/</loc>
		<lastmod>2009-08-23T15:17:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1127: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/08/23/suspension-o-retirada-de-un-cep/</loc>
		<lastmod>2009-08-23T14:17:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1119: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/08/23/fda-adopta-la-ich-q8-pharmaceutical-development/</loc>
		<lastmod>2009-08-23T13:46:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1112: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/08/22/emea-adopta-la-ich-q8-pharmaceutical-development/</loc>
		<lastmod>2009-08-22T17:39:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1106: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/08/22/antibioticos-medicamentos-a-base-de-penicilinas-y-gmps/</loc>
		<lastmod>2009-08-22T16:56:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1101: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/17/acuerdos-entre-inspecciones-farmaceuticas-internacionales/</loc>
		<lastmod>2009-07-17T07:45:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1095: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/05/politica-de-transparencia-de-emea/</loc>
		<lastmod>2009-07-05T17:29:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1086: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/01/aprender-a-utilizar-el-analisis-de-riesgos/</loc>
		<lastmod>2009-07-01T15:57:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1080: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/01/el-dossier-lote-en-el-foco-de-la-inspeccion-farmaceutica/</loc>
		<lastmod>2009-07-01T15:18:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1072: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/01/buenas-practicas-de-distribucion/</loc>
		<lastmod>2009-07-01T14:56:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1065: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/07/01/el-fututo-proximo-de-las-gmp/</loc>
		<lastmod>2009-07-01T14:13:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1053: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/06/26/seminario-practico-sobre-analisis-de-riesgos/</loc>
		<lastmod>2009-06-26T09:10:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1045: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/06/13/primer-seminario-de-formacion-especializada/</loc>
		<lastmod>2009-06-13T09:36:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1037: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/05/26/exito-en-el-seminario-de-validacion-de-procesos/</loc>
		<lastmod>2009-05-26T10:09:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 1025: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/05/01/seminario-de-formacion-validacion-de-procesos-1/</loc>
		<lastmod>2009-05-01T12:26:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 997: Comments: 10 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/30/seminario-validacion-de-procesos/</loc>
		<lastmod>2009-04-30T08:18:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 989: Comments: 8 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/21/guia-para-valorar-proveedores-de-principios-activos-farmaceuticos/</loc>
		<lastmod>2009-04-21T16:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 984: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/19/seguridad-en-la-cadena-de-suministros/</loc>
		<lastmod>2009-04-19T10:37:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 977: Comments: 192 of 991 = 0.2 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/18/validacion-de-metodos-analiticos-de-usp/</loc>
		<lastmod>2009-04-18T16:57:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 966: Comments: 11 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/18/deficiencias-y-problemas-con-la-validacion/</loc>
		<lastmod>2009-04-18T13:55:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 957: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/18/curso-sobre-gases-medicinales/</loc>
		<lastmod>2009-04-18T11:30:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 947: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/18/1%c2%aa-jornada-sobre-garantia-de-calidad-de-productos-cosmeticos/</loc>
		<lastmod>2009-04-18T09:32:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 941: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/18/las-gmp-en-la-fabricacion-de-cosmeticos/</loc>
		<lastmod>2009-04-18T08:43:53+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 930: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/17/programa-de-certificacion-gmp-de-excipientes/</loc>
		<lastmod>2009-04-17T16:00:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 921: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/17/novedades-en-la-legislacion-de-cosmeticos/</loc>
		<lastmod>2009-04-17T14:55:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 912: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/04/16/emea-revisa-las-gmp-para-implementar-ich-q10/</loc>
		<lastmod>2009-04-16T08:04:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 905: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/29/el-qualified-person-forum-2009-se-celebra-en-barcelona/</loc>
		<lastmod>2009-03-29T12:04:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 898: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/20/calidad-de-los-medicamentos-en-investigacion/</loc>
		<lastmod>2009-03-20T10:35:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 893: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/20/tienes-preguntas-sobre-ich-q8-q9-y-q10/</loc>
		<lastmod>2009-03-20T09:46:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 882: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/20/nuevo-seminario-sobre-oos-y-oot/</loc>
		<lastmod>2009-03-20T08:11:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 871: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/17/reacciones-a-nueva-guia-fda-sobre-validacion-de-procesos-22/</loc>
		<lastmod>2009-03-17T18:25:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 862: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/17/procedimientos-y-guias-para-inspecciones-gcp/</loc>
		<lastmod>2009-03-17T16:07:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 850: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/17/liberacion-de-lotes-con-desviaciones-menores/</loc>
		<lastmod>2009-03-17T15:17:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 828: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/03/08/sistema-de-trazabilidad-de-medicamentos/</loc>
		<lastmod>2009-03-08T12:49:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 822: Comments: 16 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/02/14/cadena-de-frio/</loc>
		<lastmod>2009-02-14T18:58:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 810: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/02/11/novedades-en-liberacion-parametrica/</loc>
		<lastmod>2009-02-11T18:42:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 799: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/29/seminario-sobre-gmp-del-siglo-xxi/</loc>
		<lastmod>2009-01-29T08:57:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 786: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/26/cambios-en-la-validacion-de-procesos/</loc>
		<lastmod>2009-01-26T08:52:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 779: Comments: 9 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/25/regulacion-sobre-cosmeticos-gmp-e-iso-22716/</loc>
		<lastmod>2009-01-25T18:06:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 764: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/24/normas-gmp-para-productos-cosmeticos/</loc>
		<lastmod>2009-01-24T12:33:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 750: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/14/preguntas-y-respuestas-sobre-el-real-decreto-13452007/</loc>
		<lastmod>2009-01-14T11:42:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 741: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/07/nueva-version-de-iso-9001/</loc>
		<lastmod>2009-01-07T15:04:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 730: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2009/01/07/las-gmp-del-siglo-xxi/</loc>
		<lastmod>2009-01-07T14:16:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 724: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/31/feliz-ano-2009/</loc>
		<lastmod>2008-12-31T08:13:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 713: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/24/nueva-guia-para-la-fabricacion-de-radiofarmacos/</loc>
		<lastmod>2008-12-24T10:55:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 695: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/22/validacion-de-procesos-conclusiones/</loc>
		<lastmod>2008-12-22T17:07:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 689: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/18/validacion-de-procesos-etapa-3-verificacion-continua-del-proceso/</loc>
		<lastmod>2008-12-18T19:47:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 677: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/18/validacion-de-procesos-el-protocolo-de-pq/</loc>
		<lastmod>2008-12-18T18:56:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 667: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/18/validacion-de-procesos-etapa-2-cualificacion-del-proceso/</loc>
		<lastmod>2008-12-18T18:26:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 651: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/07/validacion-de-procesos-etapa-1-diseno-del-proceso/</loc>
		<lastmod>2008-12-07T12:59:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 637: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/07/validacion-de-procesos-2%c2%aa-parte/</loc>
		<lastmod>2008-12-07T11:29:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 631: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/12/07/validacion-de-procesos-1%c2%aa-parte/</loc>
		<lastmod>2008-12-07T10:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 614: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/11/20/cualificacion-de-instalaciones-para-procesos-asepticos/</loc>
		<lastmod>2008-11-20T18:09:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 599: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/11/11/nuevo-reglamento-europeo-de-cosmeticos-enfasis-en-seguridad/</loc>
		<lastmod>2008-11-11T07:53:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 591: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/11/09/muestreo-de-materiales-de-acondicionamiento/</loc>
		<lastmod>2008-11-09T16:20:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 584: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/11/09/certificates-of-suitability-cep/</loc>
		<lastmod>2008-11-09T12:54:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 579: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/11/09/inspecciones-de-buenas-practicas-clinicas-gcp/</loc>
		<lastmod>2008-11-09T12:07:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 558: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/27/herramientas-de-garantia-de-calidad/</loc>
		<lastmod>2008-10-27T16:40:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 552: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/25/test-de-esterilidad-y-requisitos-de-muestreo/</loc>
		<lastmod>2008-10-25T17:55:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 542: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/25/auditorias-a-proveedores-realizadas-por-terceros/</loc>
		<lastmod>2008-10-25T17:08:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 524: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/25/tecnologias-contra-la-falsificacion-de-medicamentos/</loc>
		<lastmod>2008-10-25T14:51:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 511: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/24/novedades-relacionadas-con-ich-q10/</loc>
		<lastmod>2008-10-24T16:40:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 505: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/20/procedimientos-para-inspecciones-gcp/</loc>
		<lastmod>2008-10-20T08:21:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 499: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/19/emea-y-fda-incrementan-la-cooperacion-mutua/</loc>
		<lastmod>2008-10-19T15:52:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 468: Comments: 18 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/17/medicion-de-la-conductividad-del-agua/</loc>
		<lastmod>2008-10-17T16:17:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 449: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/17/reach-y-la-validacion-de-desinfectantes/</loc>
		<lastmod>2008-10-17T14:28:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 422: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/17/fabricacion-de-radiofarmacos/</loc>
		<lastmod>2008-10-17T13:05:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 413: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/10/13/excipientes-certificados-de-analisis-y-cumplimiento-de-gmp/</loc>
		<lastmod>2008-10-13T13:11:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 371: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/24/la-inspeccion-tambien-aplica-ich-q9/</loc>
		<lastmod>2008-09-24T06:23:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 355: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/16/estrenamos-nueva-imagen/</loc>
		<lastmod>2008-09-16T14:32:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 347: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/11/armonizacion-de-principios-activos-farmaceuticos/</loc>
		<lastmod>2008-09-11T14:01:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 344: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/11/ich-q11-la-nueva-guia-para-desarrollo-y-fabricacion-de-apis/</loc>
		<lastmod>2008-09-11T13:19:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 322: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/10/seminario-sobre-quality-assurance-y-gmp-del-siglo-xxi/</loc>
		<lastmod>2008-09-10T07:00:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 320: Comments: 15 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/05/actualidad-en-la-validacion-de-limpieza/</loc>
		<lastmod>2008-09-05T15:46:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 318: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/04/empowerment-calidad-y-productividad/</loc>
		<lastmod>2008-09-04T06:59:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 316: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/09/01/pat-espacio-de-diseno-y-microbiologia-rapida/</loc>
		<lastmod>2008-09-01T12:30:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 312: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/29/uso-de-desinfectantes-en-la-industria-farmaceutica/</loc>
		<lastmod>2008-08-29T09:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 310: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/29/proyecto-de-racionalizacion-de-inspecciones-gmp-en-europa/</loc>
		<lastmod>2008-08-29T07:14:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 308: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/27/plan-de-prevencion-de-riesgos-de-calidad/</loc>
		<lastmod>2008-08-27T15:47:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 305: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/27/cursos-de-formacion-para-inspectores-de-obtencion-de-tejidos/</loc>
		<lastmod>2008-08-27T14:06:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 303: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/27/impurezas-en-antibioticos/</loc>
		<lastmod>2008-08-27T12:24:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 301: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/26/emea-evalua-el-uso-de-apis-que-cumplen-gmp/</loc>
		<lastmod>2008-08-26T16:26:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 299: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/26/nueva-guidance-sobre-bioequivalencia/</loc>
		<lastmod>2008-08-26T15:37:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 297: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/26/el-fin-de-la-validacion-de-procesos/</loc>
		<lastmod>2008-08-26T13:38:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 293: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/08/23/ensayo-de-identificacion-y-toma-de-muestras/</loc>
		<lastmod>2008-08-23T15:47:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 291: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/07/30/la-estrategia-ich-vs-costes-y-recursos/</loc>
		<lastmod>2008-07-30T10:36:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 289: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/07/07/finalizada-la-ich-q10-pharmaceutical-quality-system/</loc>
		<lastmod>2008-07-07T12:39:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 274: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/05/19/cualificacion-de-instrumentos-analiticos-2/</loc>
		<lastmod>2008-05-19T18:19:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 271: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/05/14/guia-para-inspectores-de-obtencion-de-tejidos/</loc>
		<lastmod>2008-05-15T06:18:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 267: Comments: 10 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/05/11/fabricacion-de-medicamentos-esteriles/</loc>
		<lastmod>2008-05-11T11:22:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 249: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/23/cualificacion-de-equipos-de-laboratorio-2/</loc>
		<lastmod>2008-04-23T18:21:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 248: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/21/espacio-de-diseno/</loc>
		<lastmod>2008-04-21T08:26:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 247: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/20/desarrollo-farmaceutico-parte-2-de-2/</loc>
		<lastmod>2008-04-20T09:13:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 246: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/20/desarrollo-farmaceutico-parte-1-de-2/</loc>
		<lastmod>2008-04-20T08:57:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 243: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/19/validacion-de-sistemas-informaticos-22/</loc>
		<lastmod>2008-04-19T12:39:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 242: Comments: 10 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/19/validacion-de-sistemas-informaticos-12/</loc>
		<lastmod>2008-04-19T12:30:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 235: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/10/aplicacion-practica-del-pqr/</loc>
		<lastmod>2008-04-10T09:33:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 233: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/09/investigacion-de-incidencias-y-desviaciones/</loc>
		<lastmod>2008-04-09T10:19:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 230: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/07/nos-han-elegido-como-blog-del-dia/</loc>
		<lastmod>2008-04-08T05:44:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 231: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/04/07/calidad-de-los-principios-activos-de-china/</loc>
		<lastmod>2008-04-07T10:39:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 226: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/03/26/oos-out-of-specifications/</loc>
		<lastmod>2008-03-26T16:12:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 224: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/03/26/cualificacion-de-instrumentos-analiticos/</loc>
		<lastmod>2008-03-26T12:07:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 220: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/03/05/cumplimos-1-ano/</loc>
		<lastmod>2008-03-06T07:47:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 222: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/03/03/microbiologia-rapida/</loc>
		<lastmod>2008-03-03T10:01:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 201: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/20/nos-visitan-y-nos-valoran-cada-vez-mas/</loc>
		<lastmod>2008-02-20T10:15:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 213: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/18/gmp-ue-anexo-20-quality-risk-management/</loc>
		<lastmod>2008-02-18T18:08:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 210: Comments: 25 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/18/gmp-ue-anexo-1-fabricacion-de-medicamentos-esteriles/</loc>
		<lastmod>2008-02-18T15:42:02+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 207: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/16/ich-q9-iso-frente-a-gmp-e-ich-q10/</loc>
		<lastmod>2008-02-16T13:04:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 204: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/15/pqr-revision-de-la-calidad-del-producto/</loc>
		<lastmod>2008-02-15T16:59:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 202: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/13/herramientas-de-formacion-gmp-2%c2%aa-parte/</loc>
		<lastmod>2008-02-13T13:02:42+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 199: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/02/11/herramientas-de-formacion-gmp-1%c2%aa-parte/</loc>
		<lastmod>2008-02-11T10:16:43+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 195: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/28/integracion-de-ich-q9-en-las-actividades-industriales/</loc>
		<lastmod>2008-01-28T11:07:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 192: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/24/atributos-de-la-qualified-person-e-ich-q9/</loc>
		<lastmod>2008-01-24T18:33:07+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 190: Comments: 19 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/23/buenas-practicas-de-transporte-de-medicamentos/</loc>
		<lastmod>2008-01-23T15:39:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 189: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/23/retiradas-del-mercado-de-medicamentos/</loc>
		<lastmod>2008-01-23T10:39:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 186: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/21/cambios-en-las-gmp-ue/</loc>
		<lastmod>2008-01-21T09:57:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 185: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/18/cualificacion-de-equipos-de-laboratorio/</loc>
		<lastmod>2008-01-18T16:07:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 183: Comments: 5 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/18/pqr-aplicacion-practica/</loc>
		<lastmod>2008-01-18T11:35:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 182: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/17/gamp-5-en-europa/</loc>
		<lastmod>2008-01-17T13:21:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 180: Comments: 9 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2008/01/16/lanzamiento-de-gamp-5/</loc>
		<lastmod>2008-01-16T14:01:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 174: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/30/feliz-ano-nuevo/</loc>
		<lastmod>2007-12-31T01:11:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 168: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/14/ich-publica-el-anexo-de-la-q8/</loc>
		<lastmod>2007-12-14T09:38:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 167: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/14/ich-q10-el-futuro-sistema-de-calidad-farmaceutico/</loc>
		<lastmod>2007-12-14T08:24:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 165: Comments: 7 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/12/04/soluciones-para-la-industria-farmaceutica-de-hoy-parte-6/</loc>
		<lastmod>2007-12-04T17:27:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 163: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/30/soluciones-para-la-industria-farmaceutica-de-hoy-parte-5/</loc>
		<lastmod>2007-11-30T16:03:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 161: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/28/soluciones-para-la-industria-farmaceutica-de-hoy-parte-4/</loc>
		<lastmod>2007-11-28T18:57:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 159: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/28/soluciones-para-la-industria-farmaceutica-de-hoy-parte-3/</loc>
		<lastmod>2007-11-28T18:32:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 157: Comments: 10 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/26/soluciones-para-la-industria-farmaceutica-de-hoy-parte-2/</loc>
		<lastmod>2007-11-26T17:15:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 155: Comments: 15 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/26/soluciones-para-la-industria-farmaceutica-de-hoy-parte-1/</loc>
		<lastmod>2007-11-26T16:58:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 153: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/23/inspecciones-fda-principales-desviaciones-encontradas/</loc>
		<lastmod>2007-11-23T17:05:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 150: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/21/red-de-transferencia-tecnologica-colinter/</loc>
		<lastmod>2007-11-21T19:12:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 147: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/21/real-decreto-13452007/</loc>
		<lastmod>2007-11-21T18:31:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 143: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/21/fda-planea-cambios-en-su-guia-de-gmp-21-cfr-211/</loc>
		<lastmod>2007-11-21T17:05:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 145: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/11/21/el-futuro-de-los-medicamentos-de-uso-humano-en-europa-2%c2%aa-parte/</loc>
		<lastmod>2007-11-21T09:31:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 134: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/10/31/normas-de-correcta-fabricacion-de-medicamentos/</loc>
		<lastmod>2007-10-31T14:11:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 131: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/10/26/ich-q10-pharmaceutical-quality-system/</loc>
		<lastmod>2007-10-26T17:39:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 129: Comments: 27 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/10/12/nueva-version-de-la-guia-gmp-de-pics/</loc>
		<lastmod>2007-10-12T17:38:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 123: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/26/ich-q9-quality-risk-management-2%c2%aa-parte/</loc>
		<lastmod>2007-09-26T11:34:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 121: Comments: 3 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/25/validacion-de-sistemas-informaticos/</loc>
		<lastmod>2007-09-25T10:15:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 113: Comments: 6 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/16/sistema-de-gestion-de-calidad-para-la-direccion/</loc>
		<lastmod>2007-09-16T12:30:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 103: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/11/actualizacion-del-anexo-6-fabricacion-de-gases-medicinales-de-las-eu-gmp/</loc>
		<lastmod>2007-09-11T15:57:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 101: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/09/11/pat-process-analitycal-technology/</loc>
		<lastmod>2007-09-11T15:35:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 47: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/26/la-cualificacion-de-proveedores-es-uno-de-los-puntos-criticos-de-la-inspeccion-de-gmp-en-europa/</loc>
		<lastmod>2007-07-26T09:22:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 45: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/25/grupo-de-trabajo-europeo-para-la-unificacion-de-la-codificacion-de-sustancias-quimicas/</loc>
		<lastmod>2007-07-26T07:48:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 42: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/24/el-futuro-de-los-medicamentos-de-uso-humano-en-europa/</loc>
		<lastmod>2007-07-24T11:48:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 32: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/16/la-consultoria-20-en-la-nueva-industria-farmaceutica/</loc>
		<lastmod>2007-07-16T09:10:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 26: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/08/el-pqr-en-el-foco-de-la-inspeccion-farmaceutica-2/</loc>
		<lastmod>2007-07-09T07:55:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 25: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/07/04/emea-edita-un-procedimiento-sobre-coordinacion-de-inspecciones-gxp/</loc>
		<lastmod>2007-07-04T13:29:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 23: Comments: 213 of 991 = 0.2 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/06/18/sanitizacion-de-sistemas-de-agua-farmaceutica/</loc>
		<lastmod>2007-06-18T12:55:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 22: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/06/15/el-pqr-en-el-foco-de-la-inspeccion-farmaceutica/</loc>
		<lastmod>2007-06-15T15:33:31+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 20: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/06/15/implicacion-y-soporte-de-la-direccion-como-eje-fundamental-de-un-sistema-de-calidad/</loc>
		<lastmod>2007-06-15T14:59:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 19: Comments: 4 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/06/15/ich-q-10-pone-enfasis-en-el-sistema-de-gestion-de-calidad/</loc>
		<lastmod>2007-06-15T14:12:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 18: Comments: 2 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/06/01/se-a-publicado-la-ich-q-10-pharmaceutical-quality-system/</loc>
		<lastmod>2007-06-01T16:36:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 17: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/05/30/nueva-guidance-for-industry-de-fda-para-sistemas-informaticos/</loc>
		<lastmod>2007-05-30T13:42:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 12: Comments: 1 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/01/25/consultoria-20/</loc>
		<lastmod>2007-01-25T13:12:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 8: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/01/24/por-que-un-blog-y-no-una-pagina-web-convencional/</loc>
		<lastmod>2007-01-24T09:05:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: Priority report of postID 3: Comments: 0 of 991 = 0 points -->
	<url>
		<loc>http://www.fernandotazon.com.es/2007/01/18/hello-world/</loc>
		<lastmod>2007-01-19T01:53:34+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
<!-- Debug: End Postings -->
<!-- Debug: Start Custom Pages -->
<!-- Debug: End Custom Pages -->
<!-- Debug: Start additional URLs -->
<!-- Debug: End additional URLs -->
</urlset>